T1	Participants 64 96	in patients with type 2 diabetes
T2	Participants 161 188	in type 2 diabetic patients
T3	Participants 575 613	University medical center; 50 patients
T4	Participants 773 788	treatment group
T5	Participants 940 953	control group
T6	Participants 1396 1433	Chinese patients with type 2 diabetes
T7	Participants 1576 1591	treatment group
T8	Participants 1839 1854	treatment group
T9	Participants 1946 2014	17 (68%) control-group patients and 9 (36%) treatment-group patients
T10	Participants 2205 2229	type 2 diabetic patients
